Hader, Michael
Frey, Benjamin
Fietkau, Rainer
Hecht, Markus
Gaipl, Udo S. http://orcid.org/0000-0001-6375-5476
Funding for this research was provided by:
Bayerische Forschungsstiftung (Microthermia - AZ-1261-17)
Article History
Received: 30 July 2019
Accepted: 22 December 2019
First Online: 18 January 2020
Compliance with ethical standards
:
: M. Hader, U. S. Gaipl, and R. Fietkau received support for presentation activities from Dr. Sennewald Medizintechnik GmbH. R. Fietkau, U. S. Gaipl, B. Frey, and M. Hecht have received support for investigator initiated clinical studies (IITs) from Merck Sharp & Dohme and AstraZeneca. R. Fietkau, U. S. Gaipl, and M. Hecht also contributed at Advisory Boards Meetings of AstraZeneca and Bristol-Myers Squibb. M. Hecht further received travel support from Merck Serono, Merck Sharp & Dohme and Teva.